Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4738 (MIR4738, hsa-mir-4738) is a small non-coding RNA molecule belonging to the microRNA family, transcribed as a primary transcript and processed to a mature miRNA that is incorporated into the RNA-induced silencing complex (RISC) to regulate gene expression post-transcriptionally. It can bind imperfectly to target messenger RNA (such as COL1A2) and inhibit translation or cause mRNA destabilization, thereby affecting biological processes such as inflammation, apoptosis, and cell survival. MIR4738 has been associated with regulation of the NF-κB signaling pathway, cellular communication via exosomes, and plays a role in disease processes such as osteoarthritis and possibly certain cancers.
Inhibiting or mimicking MIR4738 modulates downstream genes (e.g., COL1A2) and inflammation via the NF-κB pathway. miRNA mimics inhibit gene expression by binding to mRNA 3′-UTR, leading to translational inhibition or mRNA degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4738 (MIR4738).